Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-25 Sale | 2025-03-26 4:30 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 2,631 | $6.6 | $17,365 | 221,373 (Direct) | View |
| 2025-03-21 Sale | 2025-03-25 4:30 pm | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 5,263 | $6.5789 | $34,625 | 213,313 (Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:00 pm | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 81,313 | $6.7502 | $548,878 | 145,237 (Direct) | View |
| 2024-09-06 Sale | 2024-09-09 5:00 pm | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 6,059 | $3.032 | $18,371 | 215,153 (Direct) | View |
| 2024-09-03 Sale | 2024-09-05 4:54 pm | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 55,121 | $3.0876 | $170,193 | 323,025 (Direct) | View |
| 2024-08-27 Sale | 2024-08-29 4:55 pm | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 4,555 | $2.9314 | $13,353 | 352,489 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 4:00 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $2.9633 | $48,883 | 220,315 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:47 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $2.7687 | $87,228 | 319,868 (Direct) | View |
| 2024-05-29 Sale | 2024-05-31 4:07 pm | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 53,368 | $2.5504 | $136,110 | 214,433 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:12 pm | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 4,350 | $2.6402 | $11,485 | 101,404 (Direct) | View |
| 2024-05-20 Sale | 2024-05-22 4:30 pm | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 25,037 | $2.8588 | $71,576 | 246,502 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-11 Option Award | 2025-06-13 4:09 pm | N/A 2035-06-10 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:00 pm | N/A 2035-06-10 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:00 pm | N/A 2035-06-10 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:00 pm | N/A 2035-06-10 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:00 pm | N/A 2035-06-10 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-05-31 Option Award | 2025-06-03 4:00 pm | 2025-05-31 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 8,550 | $0 | 13,110 (Direct) | View |
| 2025-05-31 Option Award | 2025-06-03 4:00 pm | 2025-05-31 2034-02-14 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 60,000 | $0 | 92,000 (Direct) | View |
| 2025-05-31 Option Award | 2025-06-03 4:00 pm | 2025-05-31 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 72,000 | $0 | 110,400 (Direct) | View |
| 2025-05-31 Option Award | 2025-06-03 4:00 pm | 2025-05-31 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 72,000 | $0 | 110,400 (Direct) | View |
| 2025-05-31 Option Award | 2025-06-03 4:00 pm | 2025-05-31 2034-02-14 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 102,000 | $0 | 156,400 (Direct) | View |
| 2025-03-25 Exercise | 2025-03-26 4:30 pm | N/A 2025-05-14 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 2,631 | $0 | 221,373 (Direct) | View |
| 2025-03-25 Exercise | 2025-03-26 4:30 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 2,631 | $1.43 | 221,373 (Direct) | View |
| 2025-03-21 Exercise | 2025-03-25 4:30 pm | N/A 2025-05-14 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 5,263 | $0 | 213,313 (Direct) | View |
| 2025-03-21 Exercise | 2025-03-25 4:30 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 5,263 | $1.43 | 213,313 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 54,400 | $0 | 54,400 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 38,400 | $0 | 38,400 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 4,560 | $0 | 4,560 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A 2031-02-16 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 112,563 | $0 | 145,237 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | 2025-03-10 2034-02-14 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 38,400 | $0 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 31,250 | $0.511 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 63,813 | $3.91 | 145,237 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 17,500 | $3.21 | 145,237 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 116,000 | $0 | 116,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer | 257,500 | $0 | 257,500 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer | 225,500 | $0 | 225,500 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 225,500 | $0 | 225,500 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 811,000 | $0 | 811,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:00 pm | N/A 2035-02-17 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 41,000 | $0 | 41,000 (Direct) | View |
| 2025-01-07 Exercise | 2025-01-10 4:14 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 6,000 | $0 | 153,910 (Direct) | View |
| 2025-01-07 Exercise | 2025-01-10 4:14 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 6,000 | $0.511 | 153,910 (Direct) | View |
| 2024-12-13 Exercise | 2024-12-17 4:30 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 15,000 | $0 | 39,935 (Direct) | View |
| 2024-12-13 Exercise | 2024-12-17 4:30 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks | 15,000 | $0.511 | 39,935 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-01 5:04 pm | N/A 2034-09-29 | Trevi Therapeutics Inc. | TRVI | Cassella James V Chief Development Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-09-06 Exercise | 2024-09-09 5:00 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 6,059 | $0 | 215,153 (Direct) | View |
| 2024-09-06 Exercise | 2024-09-09 5:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 6,059 | $1.43 | 215,153 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-05 4:54 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 55,121 | $0 | 323,025 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-05 4:54 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 55,121 | $1.43 | 323,025 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-29 4:55 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 4,555 | $0 | 352,489 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-29 4:55 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 4,555 | $1.43 | 352,489 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-21 4:00 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $0 | 220,315 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-21 4:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 16,496 | $1.43 | 220,315 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:47 pm | N/A 2024-11-24 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $0 | 319,868 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 4:47 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 31,505 | $1.43 | 319,868 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:40 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Cassella James V Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Meeker David P Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 4:07 pm | N/A 2024-07-01 | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 59,354 | $0 | 214,433 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 4:07 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer | 59,354 | $2.19 | 214,433 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-24 4:12 pm | N/A 2032-02-10 | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 16,043 | $0 | 101,404 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-24 4:12 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer | 16,043 | $0.511 | 101,404 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 4:30 pm | N/A 2024-07-01 | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 25,037 | $0 | 246,502 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-22 4:30 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO | 25,037 | $2.19 | 246,502 (Direct) | View |